AC Immune ACIU
NASDAQ ACIU
$2.86 -0.07 (-2.39%)
At close: Sep 4, 2026 · 4:00 PM EDT

AC Immune (ACIU) Change in Account Payables (2015 - 2025)

AC Immune (ACIU) posted quarterly Change in Account Payables of $414137.2 for Q4 2025, down 70.79% year-over-year from $1.4 million in Q4 2024, and up 128.44% quarter-over-quarter from -$1.5 million in Q3 2025.

Analysis

AC Immune (ACIU) Change in Account Payables (2015 - 2025) Analysis & Trends

AC Immune (ACIU) has reported Change in Account Payables for 11 consecutive years, with $414137.2 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Change in Account Payables fell 70.79% year-over-year to $414137.2; the TTM figure through Dec 2025 stood at -$713779.1 (down 161.01% YoY), while the FY2025 annual figure was -$714028.1, down 164.02% from the prior year.
  • Change in Account Payables rose to $414137.2 in Q4 2025 per ACIU's latest filing, from -$1.5 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $2.0 million in Q4 2021 and bottomed at -$2.0 million in Q1 2021.
  • Historically, Change in Account Payables has averaged -$123.93 across 5 years, with a median of $64889.3 in 2023.
  • Annual changes were most pronounced in 2022 — Change in Account Payables surged 1678.46% — and 2025, when it sank 6541.05%.
  • AC Immune's Change in Account Payables stood at $2.0 million in 2021, then sank by 137.01% to -$727653.4 in 2022, then jumped by 131.45% to $228853.0 in 2023, then surged by 519.51% to $1.4 million in 2024, then plunged by 70.79% to $414137.2 in 2025.
  • Business Quant data shows ACIU's Change in Account Payables at $414137.2 in Q4 2025, -$1.5 million in Q3 2025, and $748891.9 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 AC Immune 285.13 Mn 285.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 414,137.20
Sep 30, 2025 -1.46 Mn
Jun 30, 2025 748,891.94
Mar 31, 2025 -420,430.70
Dec 31, 2024 1.42 Mn
Sep 30, 2024 -21,929.94
Jun 30, 2024 -1.55 Mn
Mar 31, 2024 1.32 Mn
Dec 31, 2023 228,852.96
Sep 30, 2023 151,708.44
Jun 30, 2023 250,239.50
Mar 31, 2023 224,881.82
Dec 31, 2022 -727,653.36
Sep 30, 2022 1.25 Mn
Jun 30, 2022 -94,484.66
Mar 31, 2022 -1.62 Mn
Dec 31, 2021 1.97 Mn
Sep 30, 2021 -79,506.43
Jun 30, 2021 -28,512.82
Mar 31, 2021 -1.99 Mn